May 11, 2026 12:15 pm (IST)
Follow us:
Lupin launches generic Aricept tablets in the US
Mumbai/ Baltimore, Mar 31 (IBNS) Mumbai-based Lupin Limited (Lupin), a transnational pharmaceutical company producing and developing a wide range of branded and generic formulations, biotechnology products and APIs globally, announced on Thursday that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic equivalent of Eisai Inc's Aricept® Tablets, 23mg.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. works in the area of generic medicines and branded formulations.
Lupin's Donepezil Hydrochloride Tablets, 23 mg are the AB rated generic equivalent of Eisai Inc's Aricept® Tablets, 23mg. It is indicated for the treatment of dementia of the Alzheimer's type.
Aricept® had US sales of USD 47.1 million (IMS MAT December 2015).
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Jewellery stocks tumble! Titan, Senco Gold, Kalyan down up to 10% after Modi’s gold appeal
Mon, May 11 2026
Sensex crashes over 1,000 points as West Asia tensions rattle markets, oil prices surge
Mon, May 11 2026
AI takes over? Cloudflare cuts 1,100 jobs as AI surges
Fri, May 08 2026
Profit jumps 30%! Aditya Birla Capital posts strong Q4 FY26 results
Fri, May 08 2026
Claim Settlement Ratio Explained: How It Affects Your Policy
Thu, May 07 2026